Literature DB >> 21929477

Depression and medication adherence among breast cancer survivors: bridging the gap with the theory of planned behaviour.

Mark Manning1, B Ann Bettencourt.   

Abstract

Evidence suggests that more depressed breast cancer patients will less likely adhere to treatment plans. This study presents evidence that the theory of planned behaviour mediates the relation between depression and intentions to adhere to treatment plans and between depression and lack of adherence to medication regime. Two hundred and thirteen women undergoing breast cancer treatment participated in this study. Measures of depressive symptoms and planned behaviour variables were collected at the first time point; measures of medication adherence were collected at the second time point. Structural equation models were utilised to fit the data to the proposed models. Depressive symptoms were significantly correlated to both intentions and medication adherence. In support of hypotheses, the relation between depressive symptoms and treatment intention was mediated by attitudes towards health maintenance plans. The relation between depressive symptoms and medication adherence was fully mediated by the planned behaviour process. Conditions under which treatment intentions and perceptions of control in adhering to treatment were most related to medication adherence were elucidated. The results point to avenues for interventions to increase medication adherence among breast cancer patients. Manipulating attitudes and perceptions of control towards treatment plans will potentially serve to increase medication adherence.

Entities:  

Mesh:

Year:  2011        PMID: 21929477     DOI: 10.1080/08870446.2010.542815

Source DB:  PubMed          Journal:  Psychol Health        ISSN: 0887-0446


  22 in total

Review 1.  Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis.

Authors:  Brent T Mausbach; Richard B Schwab; Scott A Irwin
Journal:  Breast Cancer Res Treat       Date:  2015-06-16       Impact factor: 4.872

2.  Psychosocial correlates of appointment keeping in immigrant cancer patients.

Authors:  Rosario Costas-Muniz; Jennifer Leng; Lisa Diamond; Abraham Aragones; Julia Ramirez; Francesca Gany
Journal:  J Psychosoc Oncol       Date:  2015-01-09

3.  Sarcopenia is an independent risk factor for depression in patients with advanced lung cancer.

Authors:  Dinglong Xue; Ning Li; Lijun Li; Yaru Huang; Kaiya Men; Qingwei Meng; Shuai Zhang
Journal:  Support Care Cancer       Date:  2022-10-06       Impact factor: 3.359

4.  Do Attitudes, Mental Health Status, and Interpersonal Factors Predict COVID-19 Vaccine Hesitancy at the Early Phase of the Pandemic? A Longitudinal Study in Chinese College Students.

Authors:  Zhipeng Wu; Xin Wang; Sha Zhang; Nani Ding; Guohua Zhang; Chengjia Zhao; Huihui Xu; Xinyi Lai; Xiaolian Tu; Xue Yang
Journal:  Front Psychol       Date:  2022-05-19

Review 5.  Enhancing placebo effects: insights from social psychology.

Authors:  Jim Sliwinski; Gary R Elkins
Journal:  Am J Clin Hypn       Date:  2013-01

6.  Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.

Authors:  Erin J Aiello Bowles; Denise M Boudreau; Jessica Chubak; Onchee Yu; Monica Fujii; Janet Chestnut; Diana S M Buist
Journal:  J Oncol Pract       Date:  2012-07-17       Impact factor: 3.840

7.  Depressive symptoms in a sample of Afro-Caribbean and Latino immigrant cancer patients: a comparative analysis.

Authors:  Rosario Costas; Francesca Gany
Journal:  Support Care Cancer       Date:  2013-04-19       Impact factor: 3.603

Review 8.  Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms.

Authors:  Gisele Pereira Dias; Ronan Hollywood; Mário Cesar do Nascimento Bevilaqua; Anna Claudia Domingos da Silveira da Luz; Robert Hindges; Antonio Egidio Nardi; Sandrine Thuret
Journal:  Neuro Oncol       Date:  2014-01-26       Impact factor: 12.300

9.  A systematic review of interventions to improve adherence to endocrine therapy.

Authors:  Sue P Heiney; Pearman D Parker; Tisha M Felder; Swann Arp Adams; Omonefe O Omofuma; Jennifer M Hulett
Journal:  Breast Cancer Res Treat       Date:  2018-11-01       Impact factor: 4.872

10.  The impact of cognitive impairment on self-regulatory styles in breast cancer survivors.

Authors:  Jacqueline H Becker; Charlotte Ezratty; Nusrat Jahan; Mita Goel; Yael Tobi Harris; Jenny J Lin
Journal:  Psychooncology       Date:  2021-02-08       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.